LSKL - Inhibitor of Thrombospondin (TSP-1). CAS# 283609-79-0 Size:2mg solid ATP-competitive inhibitor of the α-

ATP-competitive inhibitor of the α- and β-isoforms of p38 MAPK in vitro (IC(50) = 5

Dacinostat (NVP-LAQ824) activates p21 promoter

Sulfonamide derivative

12(8):1548-57

Genet Mol Res

LSKL - Inhibitor of Thrombospondin (TSP-1). CAS# 283609-79-0 Size:2mg solid ATP-competitive inhibitor of the α-LSKL, Inhibitor of Thrombospondin (TSP 1) is a latency associated protein (LAP) TGF derived tetrapeptide and a competitive TGF 1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP 1) inhibits the binding of TSP 1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP 1) suppresses subarachnoid fibrosis via inhibition of TSP 1 mediated TGF 1 activity, prevents the development of chronic